Erick J. Lucera

Erick J. Lucera has a diverse work experience in the finance and biopharmaceutical industries. Erick J. has held various roles including Chief Financial Officer at Editas Medicine, AVEO Oncology, Valeritas, and Viventia Bio Inc. Erick J. has also served as a Board Member at SAb Biotherapeutics and as a member of the Board of Directors at Beyond Air®. Erick has extensive experience in financial and corporate development, including leading transitions from OTC to NASDAQ listings, developing banking syndicates, and completing financing and licensing transactions. Erick J. has a strong background in healthcare analysis and portfolio management, having worked as a VP and Healthcare Analyst at Eaton Vance and as the Founder, Managing Member, and Portfolio Manager at Intrepid Capital/Associates.

Erick J. Lucera's education history is as follows:

- Bachelor's Degree in Accounting from the University of Delaware (1986-1990)

- Master of Business Administration (M.B.A.) in Finance, General from Indiana University Bloomington (1993-1995)

- Master of Science in Finance (M.S.F.) in Quantitative Finance from Boston College Carroll School of Management (1997-1999)

- Certifications: Certified Public Accountant (1992), Charter Management Accountant from Chartered Institute of Management Accountants (1994), Chartered Financial Analyst (1997)

- Completed Lifelong Learning program (started in 2003, no end year provided)

- Completed a CPH (Public Health) degree from Harvard University (1997-2001)